Measurement of Acute Metabolite Changes Following Consumption of Microalgae Drinks
2 other identifiers
interventional
20
1 country
1
Brief Summary
Protein consumption is essential for various physiological processes, with microalgae and plant proteins gaining increasing attention due to their health benefits. To better understand how different protein types and processing methods impact health outcomes, this study aims to analyse the metabolite changes in response to different protein sources.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2026
CompletedFirst Posted
Study publicly available on registry
August 28, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
Study Completion
Last participant's last visit for all outcomes
December 31, 2027
August 28, 2026
August 1, 2026
12 months
August 19, 2026
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in metabolites found in plasma (plasma metabolomics)
Targeted metabolomics profiling of plasma will be conducted using liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS)
Baseline, 15, 30, 45, 60, 90, 120, 180, 240, 300 minutes
Changes in metabolites found in urine (urinary metabolomics)
Targeted metabolomics profiling of urine will be conducted liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS)
Baseline and 300 minutes
Secondary Outcomes (1)
Appetite
Baseline, 60, 120, 180, 240, 300 minutes
Study Arms (5)
Bead-milled microalgae
EXPERIMENTALConsume a 400 mL drink containing 20 g protein equivalent of bead-milled microalgae
Non-bead-milled microalgae
ACTIVE COMPARATORConsume a 400 mL drink containing 20 g protein equivalent of non-bead-milled microalgae
Whey protein isolate
ACTIVE COMPARATORConsume a 400 mL drink containing 20 g protein equivalent of whey protein isolate
Soy Protein Isolate
ACTIVE COMPARATORConsume a 400 mL drink containing 20 g protein equivalent of soy protein isolate
Maltodextrin
PLACEBO COMPARATORConsume a 400 mL drink containing maltodextrin matched for the energy content of 20 g protein
Interventions
Consume a 400 mL drink containing 20 g protein equivalent of bead-milled microalgae
Consume a 400 mL drink containing 20 g protein equivalent of non-bead-milled microalgae
Consume a 400 mL drink containing 20 g protein equivalent of whey protein isolate
Consume a 400 mL drink containing 20 g protein equivalent of soy protein isolate
Consume a 400 mL drink containing maltodextrin matched for the energy content of 20 g protein
Eligibility Criteria
You may qualify if:
- English-literate and able to give informed consent
- Singaporean Chinese Adults aged 21 to 60 (inclusive)
- Body mass index of 18.5 to 23.0 kg/m\^2 (inclusive)
- Healthy (Based on results from screening session)
You may not qualify if:
- Currently participating in another clinical study that involves altering the regular diet and/or involves consuming a dietary supplement or investigated food product as an intervention
- High blood pressure (≥ 140/90 mmHg)
- Underlying health conditions that may affect metabolic functions
- Consuming amino acid or protein supplements, or protein drinks, regularly (i.e., more than three times a week) for the past 3 months, and not willing to discontinue usage 3 months before and during the study duration
- Weight change \> 3 kg in the past 3 months
- Weight \< 50 kg
- Exercising vigorously over the past 3 months (i.e., engaging in high-intensity exercises for more than 3 hours a week, where high-intensity exercises leave one out of breath and unable to talk or sing during the workout)
- Current smokers or have quit smoking for less than 5 years
- Drinking \> 2 alcoholic drinks per day (i.e., one drink is defined as either 150 ml of wine, 340 ml of beer/cider or 45 ml of distilled spirit)
- If drinking ≤ 2 alcoholic drinks per day, not willing to stop consumption of alcoholic beverages two days before and on the day of the test visits
- Not willing to stop consumption of caffeinated beverages 10 to 12 houFrs before and on the day of the test visits
- Currently on a specialised diet (e.g., Halal, vegetarian, vegan, weight loss diet)
- Had serious food allergies in the past, or having intolerance, sensitivities or allergies to any of the following: seaweed or algae and their derived products, milk/dairy products (e.g., whey), starch/starch-derived products (e.g., rice, corn, wheat, potato), soy/soy-derived products, gluten, eggs, nuts, peanuts, fish and crustaceans
- Disease or impairment of the kidney and/or liver\*
- Currently diagnosed with diabetes\*, gastrointestinal issues (e.g., lactose intolerance, irritable bowel syndrome), gout and/or G6PD deficiency
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NUS, Department of Food Science and Technology, 1 Science Drive 3, Block S13, #03-07, Singapore, 117550
Singapore, Singapore
Related Publications (1)
Williamson E, Monteyne AJ, Van der Heijden I, Abdelrahman DR, Murton AJ, Hankamer B, Stephens FB, Wall BT. Ingestion of 'whole cell' or 'split cell' Chlorella sp., Arthrospira sp., and milk protein show divergent postprandial plasma amino acid responses with similar postprandial blood glucose control in humans. Front Nutr. 2024 Nov 14;11:1487778. doi: 10.3389/fnut.2024.1487778. eCollection 2024.
PMID: 39610880BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jung Eun Kim, Ph.D., R.D.
National University of Singapore, Department of Food Science and Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 19, 2026
First Posted
August 28, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
August 28, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Electronic copies of the data with identifiable participant information will be kept on NUS OneDrive with access limited only to A/P Kim Jung Eun and her research staff. All data will be de-identified prior to statistical analyses.